EICHORCondition: Pulmonary Embolism · Sponsor: Inari Medical
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UAB Division of Cardiovascular Disease | Birmingham, Alabama, United States | — |
| Brookwood Medical Center | Birmingham, Alabama, United States | — |
| Huntington Memorial Hospital | Pasadena, California, United States | — |
| University of Colorado, Denver | Aurora, Colorado, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| HCA FL Largo Medical Center | Largo, Florida, United States | — |
| AdventHealth Orlando | Orlando, Florida, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| Northwestern University | Chicago, Illinois, United States | — |
| McLaren Greater Lansing | Lansing, Michigan, United States | — |
| Saint Luke's Hospital of Kansas City | Kansas City, Missouri, United States | — |
| Mercy Hospital Springfield | Springfield, Missouri, United States | — |
+ 65 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06055920